Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology

Expands global intellectual property coverage in markets with greater late-stage breast cancer diagnoses and higher triple-negative breast cancer incidence rates New patent will provide IP protection of Breast Cancer Vaccine in Mexico into 2040 SAN JOSE, Calif., April 29, 2026...